Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 3331 AL 3345

Logopenic progressive aphasia associated with idiopathic Parkinson's disease

Matías-Guiu JA, García-Ramos R, Cabrera-Martín MN, Moreno-Ramos T.

Neurologia. 2015 Oct;30(8):521-4. doi: 10.1016/j.nrl.2014.01.007. Epub 2014 Mar 7.

Current perspectives on the link between neuroinflammation and neurogenesis

Wang B, Jin K.

Metab Brain Dis. 2015 Apr;30(2):355-65. doi: 10.1007/s11011-014-9523-6. Epub 2014 Mar 13.

Improving response inhibition in Parkinson's disease with atomoxetine

Ye Z, Altena E, Nombela C, Housden CR, Maxwell H, Rittman T, Huddleston C, Rae CL, Regenthal R, Sahakian BJ, Barker RA, Robbins TW, Rowe JB.

Biol Psychiatry. 2015 Apr 15;77(8):740-8. doi: 10.1016/j.biopsych.2014.01.024. Epub 2014 Feb 7.

Modes of physiologic H2S signaling in the brain and peripheral tissues

Paul BD, Snyder SH.

Antioxid Redox Signal. 2015 Feb 10;22(5):411-23. doi: 10.1089/ars.2014.5917. Epub 2014 May 9.

Preconditioning as a potential strategy for the prevention of Parkinson's disease

Golpich M, Rahmani B, Mohamed Ibrahim N, Dargahi L, Mohamed Z, Raymond AA, Ahmadiani A.

Mol Neurobiol. 2015 Feb;51(1):313-30. doi: 10.1007/s12035-014-8689-6. Epub 2014 Apr 3.

Relationship of falls and fear of falling to activity limitations and physical inactivity in Parkinson's disease

Bryant MS, Rintala DH, Hou JG, Protas EJ.

J Aging Phys Act. 2015 Apr;23(2):187-93. doi: 10.1123/japa.2013-0244. Epub 2014 Apr 3.

Levodopa-responsive hemiparkinsonism secondary to cystic expansion from a coiled cerebral aneurysm

Norris SA, Derdeyn CP, Perlmutter JS.

J Neuroimaging. 2015 Mar-Apr;25(2):316-318. doi: 10.1111/jon.12117. Epub 2014 Apr 7.

Memantine improves attention and episodic memory in Parkinson's disease dementia and dementia with Lewy bodies

Wesnes KA, Aarsland D, Ballard C, Londos E.

Int J Geriatr Psychiatry. 2015 Jan;30(1):46-54. doi: 10.1002/gps.4109. Epub 2014 Apr 16.

Postencephalitic parkinsonism and selective involvement of substantia nigra in childhood

Rebai I, Ben Rhouma H, Kraoua I, Klaa H, Rouissi A, Ben Youssef-Turki I, Gouider-Khouja N.

Brain Dev. 2015 Jan;37(1):153-7. doi: 10.1016/j.braindev.2014.03.009. Epub 2014 Apr 16.

Carbon monoxide and the CNS: challenges and achievements

Queiroga CS, Vercelli A, Vieira HL.

Br J Pharmacol. 2015 Mar;172(6):1533-45. doi: 10.1111/bph.12729. Epub 2014 Jul 2.

Trend of histone deacetylase inhibitors in cancer therapy: isoform selectivity or multitargeted strategy

Zhang L, Han Y, Jiang Q, Wang C, Chen X, Li X, Xu F, Jiang Y, Wang Q, Xu W.

Med Res Rev. 2015 Jan;35(1):63-84. doi: 10.1002/med.21320. Epub 2014 Apr 29.

Application of human induced pluripotent stem cells for modeling and treating neurodegenerative diseases

Payne NL, Sylvain A, O'Brien C, Herszfeld D, Sun G, Bernard CC.

N Biotechnol. 2015 Jan 25;32(1):212-28. doi: 10.1016/j.nbt.2014.05.001. Epub 2014 May 9.

Impulse control disorders in Parkinson's disease: an overview from neurobiology to treatment

Maréchal E, Denoiseux B, Thys E, Crosiers D, Pickut B, Cras P.

J Neurol. 2015 Jan;262(1):7-20. doi: 10.1007/s00415-014-7361-4. Epub 2014 May 14.

Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis

Wang HF, Yu JT, Tang SW, Jiang T, Tan CC, Meng XF, Wang C, Tan MS, Tan L.

J Neurol Neurosurg Psychiatry. 2015 Feb;86(2):135-43. doi: 10.1136/jnnp-2014-307659. Epub 2014 May 14.

Aberrant autophagy and parkinsonism: does correction rescue from disease progression?

Mishra AK, ur Rasheed MS, Shukla S, Tripathi MK, Dixit A, Singh MP.

Mol Neurobiol. 2015;51(3):893-908. doi: 10.1007/s12035-014-8744-3. Epub 2014 May 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias